Shares of Spyre Therapeutics (SYRE) have gained 0.9% over the past four weeks to close the last trading session at $22.65, but there could still be a solid upside left in the stock if short-term ...

Circ, Circulose, Re&Up Recycling Technologies and Syre have formed a new industry association to ensure that ...

Wedbush analyst David Nierengarten maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) today and set a price target of ...

In a bid to support Europe’s circular economy policies such as the Ecodesign for Sustainable Products Regulation (ESPR), ...

In a report released yesterday, Tyler Van Buren from TD Cowen maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report). The ...

Major textile-to-textile recyclers have come together to establish the T2T Alliance to drive policy changes and foster a ...

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report)’s stock price rose 6.6% during trading on Friday after the company announced better than expected quarterly earnings. The company traded as ...

Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) is projected to post its quarterly earnings results before the market opens on Thursday, March 6th.Analysts expect Spyre Therapeutics to post ...

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ: SYRE). Such investors are ...